| European Journal of Nuclear Medicine and Molecular Imaging | |
| Italic Title: | force |
| Cover: | European Journal of Nuclear Medicine and Molecular Imaging.jpg |
| Editor: | Arturo Chiti |
| Discipline: | Nuclear Medicine |
| Abbreviation: | Eur. J. Nucl. Med. Mol. Imaging |
| Publisher: | Springer Science+Business Media |
| Frequency: | Monthly |
| History: | 1976-present |
| Impact: | 9.236 |
| Impact-Year: | 2020 |
| Website: | https://www.springer.com/medicine/nuclear+medicine/journal/259 |
| Oclc: | 49348061 |
| Lccn: | 2002252212 |
| Coden: | EJNMA6 |
| Issn: | 1619-7070 |
| Eissn: | 1619-7089 |
The European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI) is a peer-reviewed medical journal published by Springer. It is the official journal of the European Association of Nuclear Medicine.[1] Since 1976, the EJNMMI has published material related to the field of nuclear medicine, including dosimetry, radiation biology, radiochemistry, radiopharmacology, molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression, and antisense methodologies. As of 2021, the EJNMMI has an impact factor of 10.057.[2]
In summer of 2011, Springer launched EJNMMI Research, a peer-reviewed open access journal, as a companion to the EJNMMI. It accommodates articles that could not be published in EJNMMI.